NVDA

175.04

-0.45%↓

AAPL

251.52

+0.13%↑

MSFT

372.3

-2.83%↓

TSM

343.1

+1.26%↑

AVGO.US

317.9

-1.48%↓

NVDA

175.04

-0.45%↓

AAPL

251.52

+0.13%↑

MSFT

372.3

-2.83%↓

TSM

343.1

+1.26%↑

AVGO.US

317.9

-1.48%↓

NVDA

175.04

-0.45%↓

AAPL

251.52

+0.13%↑

MSFT

372.3

-2.83%↓

TSM

343.1

+1.26%↑

AVGO.US

317.9

-1.48%↓

NVDA

175.04

-0.45%↓

AAPL

251.52

+0.13%↑

MSFT

372.3

-2.83%↓

TSM

343.1

+1.26%↑

AVGO.US

317.9

-1.48%↓

NVDA

175.04

-0.45%↓

AAPL

251.52

+0.13%↑

MSFT

372.3

-2.83%↓

TSM

343.1

+1.26%↑

AVGO.US

317.9

-1.48%↓

Search

Sensata Technologies Holding NV

Închisă

SectorTehnologie

36.35 4.85

Rezumat

Modificarea prețului

24h

Curent

Minim

34.01

Maxim

36.73

Indicatori cheie

By Trading Economics

Venit

226M

63M

Vânzări

-14M

918M

P/E

Medie Sector

162.143

77.27

EPS

0.88

Randament dividend

1.4

Marjă de profit

6.885

Angajați

16,700

EBITDA

145M

258M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+21.55% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.40%

2.29%

Următoarele câștiguri

7 mai 2026

Data viitoare de dividende

27 mai 2026

Următoarea dată ex-dividende

13 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-408M

5B

Deschiderea anterioară

31.5

Închiderea anterioară

36.35

Sentimentul știrilor

By Acuity

50%

50%

163 / 376 Clasament în Technology

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Sensata Technologies Holding NV Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 mar. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar. 2026, 22:55 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar. 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar. 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar. 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar. 2026, 22:42 UTC

Market Talk
Evenimente importante

Global Equities Roundup: Market Talk

23 mar. 2026, 22:42 UTC

Market Talk
Evenimente importante

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar. 2026, 22:40 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar. 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar. 2026, 22:22 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar. 2026, 22:19 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar. 2026, 22:19 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar. 2026, 22:18 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar. 2026, 22:15 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar. 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar. 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar. 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar. 2026, 21:10 UTC

Evenimente importante

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar. 2026, 20:50 UTC

Market Talk
Câștiguri
Evenimente importante

Basic Materials Roundup: Market Talk

Comparație

Modificare preț

Sensata Technologies Holding NV Așteptări

Obiectiv de preț

By TipRanks

21.55% sus

Prognoză pe 12 luni

Medie 40.33 USD  21.55%

Maxim 50 USD

Minim 34 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruSensata Technologies Holding NV - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

9 ratings

3

Cumpărare

5

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

21.4 / N/ASuport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Weak Bearish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

163 / 376 Clasament în Tehnologie

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Sensata Technologies Holding NV

Sensata Technologies Holding plc develops, manufactures, and sells sensors and sensor-rich solutions, electrical protection components and systems, and other products used in mission-critical systems and applications in the United States and internationally. It operates in two segments, Performance Sensing and Sensing Solutions. The Performance Sensing segment offers pressure, temperature, and position sensors, high-voltage solutions, and other solutions used in mission-critical systems and applications, such as tire pressure monitoring, thermal management, electrical protection, regenerative braking, powertrain for engine/transmission, and exhaust management for automobiles, on-road trucks, and off-road equipment customers. The Sensing Solutions segment provides application-specific sensor and electrical protection products, such as pressure, temperature, and position sensors; motor and compressor protectors; high-voltage contactors; solid state relays; bimetal electromechanical controls; power inverters; charge controllers; battery management systems; operator controls; and power conversion systems. It serves automotive, on-road truck, construction, and original equipment manufacturers in agriculture, control, appliance, medical, energy and charging infrastructure, data/telecom, and aerospace and defense industries, as well as systems integrators, aerospace, and motor and compressor distributors. Sensata Technologies Holding plc was founded in 1916 and is headquartered in Attleboro, Massachusetts.
help-icon Live chat